{"gene":"HSF2","run_date":"2026-06-10T01:55:22","timeline":{"discoveries":[{"year":1991,"finding":"HSF2 encodes a protein that binds heat shock elements (HSEs) with specificity identical to HeLa HSF and stimulates transcription from a heat shock promoter, establishing it as a distinct human heat shock transcription factor paralog separate from HSF1.","method":"cDNA cloning, in vitro DNA-binding assay, transcriptional reporter assay, antibody cross-reactivity","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct biochemical reconstitution (DNA binding, transcriptional activation) with multiple orthogonal methods in founding paper","pmids":["1871106"],"is_preprint":false},{"year":1994,"finding":"HSF2 forms trimers and binds HSEs composed of alternating inverted pentameric nGAAn repeats, but exhibits less cooperative DNA binding than HSF1; sequences within or adjacent to the HSF1 DNA-binding domain (not shared by HSF2) confer the higher cooperativity to HSF1, as demonstrated by chimeric HSF1/HSF2 proteins.","method":"In vitro DNA-binding selection (SELEX), mutagenesis of HSEs, chimeric protein analysis, gel-shift assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with mutagenesis and chimeric protein analysis, multiple orthogonal methods","pmids":["7935474"],"is_preprint":false},{"year":1994,"finding":"HSF2 is present as a trimer in mouse embryonal carcinoma (EC) cells and exhibits constitutive HSE-binding activity, but trimerization and nuclear localization of HSF2 are not sufficient for in vivo binding to the hsp70 HSE in unstressed EC cells, and HSF2 does not stimulate hsp70 or hsp86 transcription under these conditions.","method":"Gel-shift assay, transcription run-on assay, genomic footprinting, immunoblotting","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (gel shift, genomic footprinting, run-on transcription) in single rigorous study","pmids":["8035809"],"is_preprint":false},{"year":1998,"finding":"HSF2 activation is triggered by inhibition of the ubiquitin-proteasome pathway; HSF2 is a labile protein whose activation requires both continued protein synthesis and reduced proteasomal degradation, establishing proteasome dysfunction as a stress signal for HSF2.","method":"Proteasome inhibitor treatment (hemin, MG132, lactacystin), ts85 cell line (E1 ubiquitin-activating enzyme mutant), DNA-binding assays, immunoblotting","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple inhibitors and genetic model (ts85) converge on same conclusion, replicated across conditions","pmids":["9710593"],"is_preprint":false},{"year":2000,"finding":"HSF2 physically interacts with the PR65/A scaffolding subunit of PP2A and competes with the PP2A catalytic subunit for binding; this competition maps to lysine 416 within the intra-repeat loop of HEAT repeat 11 of PR65, shared by both HSF2 and the catalytic subunit binding interface.","method":"Co-immunoprecipitation, pulldown with point mutants of PR65","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal binding with mutagenesis mapping, single lab","pmids":["10872807"],"is_preprint":false},{"year":2003,"finding":"HSF2-null mice exhibit brain abnormalities (enlarged lateral and third ventricles, reduced hippocampus and striatum), meiotic defects in spermatogenesis (apoptosis of spermatocytes, synaptonemal complex structural defects), and female subfertility, demonstrating essential roles in brain development and gametogenesis.","method":"Targeted gene disruption (knockout mouse), histology, immunohistochemistry","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic KO with defined phenotypic readouts, independently replicated by a second group (PMID 12748967)","pmids":["12032072","12748967"],"is_preprint":false},{"year":2003,"finding":"HSF2 physically interacts with HSF1 and localizes to nuclear stress granules upon heat shock; deletion mutant analysis shows HSF2 influences HSF1 localization to stress granules; stress granule dynamics coincide with nucleolar Hsp70 accumulation.","method":"Co-immunoprecipitation, immunofluorescence, deletion mutant analysis, live-cell imaging","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP and deletion mutants in single lab, two orthogonal methods","pmids":["12865437"],"is_preprint":false},{"year":2004,"finding":"Genetic disruption of both hsf1 and hsf2 causes male sterility with more severe spermatogenesis defects than either single knockout alone, including failure of germ cells to progress past pachytene and loss of transcription of spermatogenesis-specific genes, demonstrating additive/synergistic transcriptional roles in spermatogenesis.","method":"Double-knockout mouse genetics, histology, RT-PCR","journal":"Genesis","confidence":"High","confidence_rationale":"Tier 2 / Strong — double KO genetic epistasis with defined cellular and molecular phenotype","pmids":["14994269"],"is_preprint":false},{"year":2006,"finding":"Upon proteasome inhibition, HSF1 and HSF2 form heterocomplexes that bind to the clusterin heat shock element (CLE) and activate clusterin transcription; gel-filtration indicates these heterocomplexes have the same apparent mass as HSF1 homotrimers, suggesting HSF1-HSF2 heterotrimer formation.","method":"Gel mobility-shift assay, supershift assay, chromatin immunoprecipitation (ChIP), co-immunoprecipitation, gel-filtration analysis, promoter deletion/mutation studies","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal methods (gel shift, supershift, ChIP, co-IP, gel filtration) in single study","pmids":["16336210"],"is_preprint":false},{"year":2007,"finding":"HSF2 participates in heat-shock-inducible hsp70 promoter occupancy and modulates HSF1-mediated Hsp gene expression; intact HSF1 is required for maximal HSF2 promoter occupancy, indicating HSF1 influences HSF2 DNA-binding activity at the hsp70 promoter.","method":"Chromatin immunoprecipitation (ChIP), real-time RT-PCR, HSF2 knockdown/overexpression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP on chromatin with quantitative expression analysis, two orthogonal methods, single lab","pmids":["17213196"],"is_preprint":false},{"year":2007,"finding":"HSF2 binds constitutively to HSE elements in the Hsp90, Hsp27, and c-Fos promoters during mitosis (gene bookmarking); RNAi-mediated reduction of HSF2 leads to decreased protein levels of Hsp90, Hsp27, and c-Fos, establishing HSF2 as required for their expression.","method":"Chromatin immunoprecipitation, RNA interference (RNAi), immunoblotting","journal":"Cell stress & chaperones","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus RNAi with protein-level readout, single lab","pmids":["17915561"],"is_preprint":false},{"year":2008,"finding":"HSF2 interacts with the polycomb protein MEL-18 and the SUMO E2 enzyme UBC9; MEL-18 binding to HSF2 inhibits HSF2 sumoylation by blocking UBC9 activity; this interaction decreases during mitosis, explaining the observed increase in HSF2 sumoylation during mitosis.","method":"Co-immunoprecipitation, RNA interference, overexpression, sumoylation assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP with RNAi and overexpression validation, single lab","pmids":["18211895"],"is_preprint":false},{"year":2008,"finding":"HSF2 occupies Y chromosome MSYq gene promoters in mouse testis in vivo; HSF2 disruption causes reduced expression of MSYq-resident multicopy genes, sperm head abnormalities, altered chromatin packing proteins, and increased sperm DNA fragmentation, defining HSF2 as a regulator of Y-chromosome gene transcription required for correct chromatin organization in sperm.","method":"ChIP-chip (promoter microarray), Hsf2 knockout mouse, RT-PCR, immunofluorescence, TUNEL assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide ChIP-chip plus KO mouse with molecular and cellular phenotype, multiple orthogonal methods","pmids":["18682557"],"is_preprint":false},{"year":2008,"finding":"HSF1 and HSF2 are both bound to the Hspa1b (hsp70.1) promoter in epididymal spermatozoa (gene bookmarking), with HSF2 binding increasing from early to late spermatids, suggesting a mechanism for rapid transcription-competence during zygotic genome activation after fertilization.","method":"Chromatin immunoprecipitation (ChIP), Western blot, immunofluorescence","journal":"Biology of reproduction","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP in primary cells with staged analysis, single lab","pmids":["18434628"],"is_preprint":false},{"year":2008,"finding":"HSF2 directly interacts with PRC1 (Protein Regulating Cytokinesis 1) specifically during mitosis; PRC1 co-localizes with HSF2 during mitosis and is associated with the hsp70i promoter during this phase, suggesting HSF2-PRC1 interaction provides a mechanistic basis for the cytokinesis defects observed in HSF2-null cells.","method":"Co-immunoprecipitation, co-localization by immunofluorescence, chromatin immunoprecipitation","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP with ChIP and co-localization, specificity confirmed (HSF1 does not interact), single lab","pmids":["18570919"],"is_preprint":false},{"year":2011,"finding":"HSF2 and HSF4 both bind to discontinuous HSE sequences in the HIF-1α promoter and cooperate to maintain HIF-1α transcription in a repressed state; downregulation of either HSF activates HIF-1α transcription, and overexpression of either displaces the other from the promoter, showing a competitive balance is required.","method":"Genome-wide EST screen, ChIP, promoter reporter assay, siRNA knockdown, overexpression","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus reporter assay plus knockdown/overexpression, multiple methods, single lab","pmids":["21258402"],"is_preprint":false},{"year":2012,"finding":"A heterozygous missense mutation R502H in human HSF2 causes complete loss of HSF2 transcriptional function and suppresses wild-type HSF2 function through a dominant-negative mechanism, establishing a link between HSF2 loss-of-function and idiopathic azoospermia.","method":"Sequencing of patient cohort, functional transcriptional assay of mutant vs. wild-type HSF2","journal":"Human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional assay in human patient-derived mutation, single lab","pmids":["23064888"],"is_preprint":false},{"year":2014,"finding":"HSF2 expression declines during mitosis, and this decline allows HSF1 and RNA polymerase II to access condensed chromatin for stress-inducible Hsp expression; HSF2-deficient cells show reduced mitotic errors and improved survival upon acute stress, demonstrating that HSF2 normally restricts stress-inducible transcription during mitosis.","method":"HSF2 knockout/knockdown cells, immunofluorescence, ChIP, flow cytometry (mitotic errors, apoptosis), RT-PCR","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with multiple orthogonal readouts (ChIP, transcription, mitotic errors, survival) in single rigorous study","pmids":["25202032"],"is_preprint":false},{"year":2015,"finding":"HSF2 negatively autoregulates its own transcription by binding to an HSE in its own promoter (~1.5 kb downstream of TSS), forming a negative autoregulatory loop.","method":"Luciferase reporter assay, ChIP, RT-PCR after HSF2 transfection","journal":"International journal of molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus reporter assay plus endogenous mRNA readout, single lab","pmids":["26260034"],"is_preprint":false},{"year":2016,"finding":"Crystal structures of the human HSF2 DNA-binding domain (DBD) bound to DNA reveal a C-terminal helix that directs wrapping of the coiled-coil domain around DNA, exposing paralog-specific DBD surface sequences for differential post-translational modifications and cofactor interactions; a direct interaction between HSF1 and HSF2 through their coiled-coil domains was also demonstrated.","method":"X-ray crystallography, co-immunoprecipitation of HSF1-HSF2 coiled-coil interaction","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with functional validation (Co-IP of coiled-coil interaction), single rigorous study","pmids":["26727490"],"is_preprint":false},{"year":2017,"finding":"DOX-induced mitochondrial ROS activate ERK1/2, which promotes HSF2 nuclear translocation and deSUMOylation, leading to HSF2 binding to the AT1R promoter and upregulating AT1R expression, contributing to cardiomyocyte apoptosis and cardiotoxicity.","method":"Immunofluorescence (nuclear translocation), DNA-binding assay, siRNA knockdown, overexpression, in vitro and in vivo cardiomyocyte models","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — nuclear translocation, DNA binding, and functional apoptosis readout linked, single lab","pmids":["28295305"],"is_preprint":false},{"year":2017,"finding":"MEL18 inhibits SUMO-1-mediated SUMOylation of HSF2 (specifically at lysine 82) by interacting with UBC9 and blocking its activity; loss of HSF2 SUMOylation activates IGF-IIR transcription and induces cardiac hypertrophy; angiotensin II receptor blockade restores HSF2 SUMOylation.","method":"Co-immunoprecipitation, SUMOylation assay, site-directed mutagenesis (K82), Western blot, in vivo spontaneously hypertensive rat model","journal":"International journal of cardiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — SUMOylation site mapping with mutagenesis plus in vivo validation, single lab","pmids":["29180262","29270451"],"is_preprint":false},{"year":2017,"finding":"p53 activation by angiotensin II represses miR-18, which de-represses HSF2 expression; elevated HSF2 then activates IGF-IIR transcription, inducing cardiomyocyte hypertrophy; cardiac-specific miR-18 overexpression protects against hypertension-induced heart failure.","method":"miRNA target site validation (3'-UTR luciferase), adenovirus-AAV gene transfer, in vitro NRVM model, in vivo transgenic overexpression","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — 3'-UTR reporter assay plus in vivo genetic model, single lab","pmids":["28796250"],"is_preprint":false},{"year":2019,"finding":"HSF2 interacts with EHMT2 (G9a histone methyltransferase) to epigenetically silence FBP1 via histone methylation, thereby promoting aerobic glycolysis (Warburg effect) and HCC cell proliferation.","method":"Co-immunoprecipitation, siRNA knockdown, ChIP, proliferation and glycolysis assays","journal":"American journal of cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and ChIP with functional readout, single lab","pmids":["31497345"],"is_preprint":false},{"year":2020,"finding":"HSF1 directly binds an HSE located 1,397 bp upstream of the HSF2 transcription start site in the HSF2 promoter and drives de novo HSF2 mRNA transcription during proteasome inhibition (bortezomib treatment); bortezomib-induced HSF2 localizes in the nucleus, interacts with HSF1, and participates in cancer cell migration.","method":"Chromatin immunoprecipitation, EMSA, promoter-reporter assay, RT-PCR, immunofluorescence, migration assay","journal":"Cellular and molecular life sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP, EMSA, and reporter assay converge on HSF1 binding to HSF2 promoter, single lab","pmids":["32607595"],"is_preprint":false},{"year":2021,"finding":"Endogenous HSF2 co-precipitates with ATP-bound (closed-form) HSP90, mirroring HSF1's known interaction with HSP90; treatment with gambogic acid or gambogenic acid disrupts both HSP90-HSF1 and HSP90-HSF2 interactions and induces a thiol-dependent heat shock response that is HSF1-dependent.","method":"Co-immunoprecipitation with HSP90 mutants, HSF1/HSF2 knockout cells, immunoblotting","journal":"Cell stress & chaperones","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with KO validation and HSP90 mutants, single lab","pmids":["34331200"],"is_preprint":false},{"year":2022,"finding":"CBP/EP300 acetyltransferases directly interact with HSF2 and acetylate it, leading to HSF2 protein stabilization; loss of CBP/EP300 function (as in Rubinstein-Taybi syndrome) reduces HSF2 levels and disrupts a CBP/EP300-HSF2-N-cadherin cascade required for neuroepithelial integrity in cerebral organoids.","method":"Co-immunoprecipitation, acetylation assay, patient-derived iPSC organoids, 2D/3D cellular models, Western blot","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — acetylation biochemistry plus patient-derived cell models plus organoid phenotype, multiple orthogonal methods","pmids":["36385105"],"is_preprint":false},{"year":2022,"finding":"HSF2 physically and functionally interacts with HSF1 across diverse cancer types; HSF1 and HSF2 share notably similar chromatin occupancy and co-regulate a common set of target genes (including HSPs and non-canonical cancer-supporting genes); loss of HSF2 impairs response to nutrient stress and reduces tumor progression in xenografts.","method":"Co-immunoprecipitation, ChIP-seq, xenograft tumor models, CRISPR/siRNA loss-of-function","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-seq plus Co-IP plus in vivo xenograft, multiple orthogonal methods","pmids":["35294249"],"is_preprint":false},{"year":2025,"finding":"HDAC1 interacts with HSF2 and destabilizes the HSF2 protein through its catalytic deacetylase activity, driving HSF2 poly-ubiquitination and proteasomal degradation under both normal and stress conditions; HDAC1 and HSF2 co-localize in developing mouse cortex and human cerebral organoids.","method":"Unbiased co-immunoprecipitation screen, catalytic mutant analysis, ubiquitination assay, proteasome inhibitor rescue, immunohistochemistry in mouse cortex and human organoids","journal":"Cell stress & chaperones","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — unbiased screen with mechanistic follow-up (catalytic mutant, ubiquitination), in vivo tissue validation, single lab","pmids":["40318841"],"is_preprint":false},{"year":2025,"finding":"TGF-β signaling downregulates HSF2 expression to enable acquisition of an invasive phenotype in breast cancer; ectopic HSF2 expression inhibits TGF-β-mediated EMT gene expression and invasive properties; temporal HSF2 downregulation is required for EMT activation, while sustained HSF2 promotes proliferation over invasion.","method":"Cell-based models, in vivo zebrafish xenografts, ectopic expression, human patient tissue analysis (IHC), RT-PCR","journal":"Science advances","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo (zebrafish) models with ectopic expression rescue and human tissue correlation, single lab","pmids":["40901953"],"is_preprint":false},{"year":2026,"finding":"HSF2 forms a genotoxic stress-responsive axis with its client chaperone HSP110; HSF2 loss increases DNA damage and IR sensitivity by impairing RNA Pol II processivity and CTD phosphorylation at serine 7, leading to transcriptional dysregulation, replication conflicts, altered pre-mRNA splicing, and reduced DNA repair gene expression; in vivo, HSF2 loss accelerates IR-induced T cell lymphoma.","method":"HSF2/HSP110 knockout cells, irradiation assays, RNA Pol II ChIP, CTD phosphorylation assays (Western blot), pre-mRNA splicing analysis, in vivo mouse lymphoma model","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with multiple molecular readouts (ChIP, phosphorylation, splicing) plus in vivo tumor model, single rigorous study","pmids":["41995727"],"is_preprint":false}],"current_model":"HSF2 is a stress-responsive and developmentally regulated transcription factor that binds HSEs as trimers with lower cooperativity than HSF1; it physically interacts with HSF1 through coiled-coil domains (structurally defined by crystal structures) to form heterocomplexes that co-occupy promoters and co-regulate Hsp and non-canonical target genes in stress responses, development, cancer, and genome maintenance; its activity is modulated by ubiquitin-proteasome-dependent protein stability, SUMO-1 conjugation (regulated by MEL18/UBC9), acetylation-mediated stabilization by CBP/EP300 (countered by HDAC1-driven destabilization), nuclear translocation downstream of ERK1/2 and ROS, interaction with HSP90, HSF4, PRC1, and PP2A-PR65; HSF2 is essential for spermatogenesis, brain development, MSYq gene regulation in sperm, and genome stability via a HSF2-HSP110-RNA Pol II axis, and it acts as a stage-specific switch between proliferation and invasion in cancer through TGF-β-mediated regulation."},"narrative":{"mechanistic_narrative":"HSF2 is a stress-responsive and developmentally regulated transcription factor that binds heat shock elements (HSEs) as trimers and stimulates transcription from heat shock promoters [PMID:1871106, PMID:7935474]. It binds inverted nGAAn pentameric repeats with lower cooperativity than its paralog HSF1, a difference traced to HSF1-specific sequences in/around the DNA-binding domain [PMID:7935474], and crystal structures of the HSF2 DBD–DNA complex show a C-terminal helix that wraps the coiled-coil around DNA and exposes paralog-specific surfaces for differential modification and cofactor binding [PMID:26727490]. A central feature of HSF2 biology is its physical and functional partnership with HSF1: the two interact through their coiled-coil domains [PMID:26727490], form heterotrimeric complexes that bind composite HSEs (e.g. the clusterin CLE) and co-occupy promoters [PMID:16336210, PMID:17213196], and share extensive chromatin occupancy to co-regulate Hsp and non-canonical target genes in stress and cancer [PMID:35294249]. HSF2 acts in gene bookmarking, binding HSE-containing promoters (Hsp90, Hsp27, c-Fos, hsp70) during mitosis, and its level must decline in mitosis to permit HSF1/RNA Pol II access to condensed chromatin for stress-inducible transcription [PMID:17915561, PMID:25202032]. HSF2 is a short-lived protein whose abundance and activity are set by proteostasis and post-translational modification: proteasome inhibition activates it [PMID:9710593], CBP/EP300-mediated acetylation stabilizes it while HDAC1-driven deacetylation promotes its poly-ubiquitination and degradation [PMID:36385105, PMID:40318841], and SUMOylation at K82 (controlled by MEL18 blockade of UBC9) modulates its target output [PMID:18211895, PMID:29180262, PMID:29270451]. Developmentally, HSF2 is essential for spermatogenesis and brain development: knockout mice show meiotic and synaptonemal defects and brain abnormalities [PMID:12032072, PMID:12748967], it occupies and regulates Y-chromosome MSYq multicopy genes required for proper sperm chromatin [PMID:18682557], and a dominant-negative R502H mutation links HSF2 loss-of-function to idiopathic azoospermia [PMID:23064888]. In cancer it functions as a stage-specific switch, with TGF-β-driven downregulation enabling EMT and invasion while sustained expression favors proliferation [PMID:40901953], and it maintains genome stability through an HSF2–HSP110 axis that supports RNA Pol II processivity and CTD serine-7 phosphorylation, with HSF2 loss accelerating irradiation-induced lymphoma [PMID:41995727].","teleology":[{"year":1991,"claim":"Establishing that a distinct human gene encodes an HSE-binding transcriptional activator defined HSF2 as a heat-shock transcription factor separate from HSF1.","evidence":"cDNA cloning with in vitro DNA-binding and reporter assays","pmids":["1871106"],"confidence":"High","gaps":["Did not establish physiological conditions of activation","No distinction of HSF2-specific versus HSF1-shared targets"]},{"year":1994,"claim":"Defining HSF2 trimerization and its lower DNA-binding cooperativity relative to HSF1 explained how the two paralogs differ biochemically despite recognizing the same HSE.","evidence":"SELEX, HSE mutagenesis, and chimeric HSF1/HSF2 gel-shift analysis; trimer detection and genomic footprinting in EC cells","pmids":["7935474","8035809"],"confidence":"High","gaps":["Trimerization and nuclear localization insufficient for in vivo binding in unstressed cells — the gating signal was unidentified","Did not define endogenous activating stimulus"]},{"year":1998,"claim":"Identifying proteasome dysfunction as an HSF2 activating signal showed that HSF2 activity is gated by protein stability rather than only by trimerization.","evidence":"Proteasome inhibitors and ts85 (E1 mutant) cells with DNA-binding and immunoblot readouts","pmids":["9710593"],"confidence":"High","gaps":["Ubiquitin ligase and degron not defined","Link between stabilization and target gene choice unclear"]},{"year":2000,"claim":"Mapping HSF2 binding to the PR65/A scaffold of PP2A, competing with the catalytic subunit, suggested HSF2 could influence phosphatase assembly.","evidence":"Co-IP and pulldown with PR65 point mutants (K416)","pmids":["10872807"],"confidence":"Medium","gaps":["Functional consequence for PP2A activity or HSF2 signaling not established","Single lab, no in vivo validation"]},{"year":2003,"claim":"Knockout mice assigned HSF2 essential developmental roles, showing it is required for brain development and meiotic progression in gametogenesis.","evidence":"Targeted gene disruption with histology and immunohistochemistry (replicated by a second group)","pmids":["12032072","12748967"],"confidence":"High","gaps":["Direct transcriptional targets driving the phenotypes not defined in this study","Mechanism of synaptonemal complex defect unresolved"]},{"year":2003,"claim":"Demonstrating HSF2–HSF1 interaction and shared localization to nuclear stress granules established physical cross-talk between the paralogs during stress.","evidence":"Co-IP, immunofluorescence, deletion mutants, live-cell imaging","pmids":["12865437"],"confidence":"Medium","gaps":["Functional output of stress-granule localization not defined","Stoichiometry of the HSF1-HSF2 complex unknown at this stage"]},{"year":2004,"claim":"Double-knockout epistasis showed HSF1 and HSF2 act additively/synergistically in spermatogenesis, demonstrating overlapping transcriptional programs in germ cells.","evidence":"hsf1/hsf2 double-KO mouse genetics, histology, RT-PCR","pmids":["14994269"],"confidence":"High","gaps":["Did not resolve which targets are co-regulated versus paralog-specific","Molecular basis of pachytene arrest unclear"]},{"year":2006,"claim":"Showing HSF1-HSF2 heterocomplexes bind the clusterin CLE provided direct evidence for heterotrimeric co-occupancy activating a non-Hsp target.","evidence":"Gel shift/supershift, ChIP, co-IP, gel filtration, promoter mutation","pmids":["16336210"],"confidence":"High","gaps":["Heterotrimer subunit ratio inferred from apparent mass, not directly counted","Generality across promoters not tested"]},{"year":2007,"claim":"Establishing reciprocal dependency — HSF1 required for maximal HSF2 promoter occupancy — refined how the paralogs jointly control Hsp70 induction.","evidence":"ChIP, RT-PCR, HSF2 knockdown/overexpression","pmids":["17213196"],"confidence":"High","gaps":["Whether HSF2 acts as activator or modulator context-dependent","No structural basis at this stage"]},{"year":2007,"claim":"Demonstrating constitutive mitotic HSF2 occupancy of Hsp90, Hsp27 and c-Fos promoters defined HSF2 as a gene-bookmarking factor required for their expression.","evidence":"ChIP plus RNAi with protein-level readout","pmids":["17915561"],"confidence":"Medium","gaps":["Mechanism allowing binding to condensed chromatin not defined","Single lab"]},{"year":2008,"claim":"Identifying MEL-18/UBC9 control of HSF2 SUMOylation and PRC1 interaction during mitosis linked HSF2 modification state to cell-cycle phase and cytokinesis.","evidence":"Co-IP, RNAi, overexpression, sumoylation assays, ChIP, co-localization","pmids":["18211895","18570919"],"confidence":"Medium","gaps":["Functional impact of mitotic SUMOylation on transcription not fully resolved","PRC1-HSF2 link to cytokinesis defect correlative"]},{"year":2008,"claim":"ChIP-chip in testis assigned HSF2 direct regulation of Y-chromosome MSYq multicopy genes required for correct sperm chromatin packaging.","evidence":"ChIP-chip, Hsf2 KO mouse, RT-PCR, immunofluorescence, TUNEL; staged ChIP of bookmarking in spermatozoa","pmids":["18682557","18434628"],"confidence":"High","gaps":["Downstream chromatin protein regulation mechanism partial","Contribution to post-fertilization genome activation inferred"]},{"year":2011,"claim":"Showing HSF2 and HSF4 competitively co-repress HIF-1α extended HSF2's repertoire to transcriptional repression with another paralog partner.","evidence":"EST screen, ChIP, reporter assay, siRNA, overexpression","pmids":["21258402"],"confidence":"Medium","gaps":["Physiological context of HSF2-HSF4 balance untested in vivo","Single lab"]},{"year":2012,"claim":"A dominant-negative R502H mutation abolishing HSF2 transcriptional function linked HSF2 loss-of-function to idiopathic azoospermia in humans.","evidence":"Patient cohort sequencing and functional transcriptional assay of mutant","pmids":["23064888"],"confidence":"Medium","gaps":["Causality in patients correlative beyond functional assay","Penetrance and modifier effects unknown"]},{"year":2014,"claim":"Demonstrating that mitotic decline of HSF2 is required to permit HSF1/Pol II chromatin access reframed HSF2 as a restrictor of stress-inducible transcription during mitosis.","evidence":"HSF2 KO/knockdown cells, immunofluorescence, ChIP, flow cytometry, RT-PCR","pmids":["25202032"],"confidence":"High","gaps":["Mechanism timing HSF2 decline not fully defined","Relationship to bookmarking role nuanced"]},{"year":2015,"claim":"Identifying an HSE in the HSF2 promoter that mediates negative autoregulation showed HSF2 tunes its own abundance.","evidence":"Luciferase reporter, ChIP, RT-PCR after HSF2 transfection","pmids":["26260034"],"confidence":"Medium","gaps":["Physiological conditions where autoregulation dominates unclear","Single lab"]},{"year":2016,"claim":"Crystal structures of the HSF2 DBD–DNA complex revealed how a C-terminal helix directs coiled-coil wrapping and exposes paralog-specific surfaces, and confirmed direct HSF1-HSF2 coiled-coil interaction.","evidence":"X-ray crystallography and Co-IP of coiled-coil interaction","pmids":["26727490"],"confidence":"High","gaps":["Full-length heterotrimer structure not solved","Direct mapping of exposed surfaces to specific modifications not shown"]},{"year":2017,"claim":"Linking ROS/ERK1/2-driven HSF2 nuclear translocation and deSUMOylation to AT1R/IGF-IIR induction, and miR-18/p53 control of HSF2 levels, placed HSF2 in cardiac stress and hypertrophy signaling.","evidence":"Immunofluorescence, DNA-binding, siRNA/overexpression, SUMOylation site mutagenesis (K82), and in vivo cardiac models","pmids":["28295305","29180262","29270451","28796250"],"confidence":"Medium","gaps":["Direct versus indirect transcriptional contributions partly inferred","Single-lab cardiac models"]},{"year":2019,"claim":"Showing HSF2-EHMT2 silencing of FBP1 to drive aerobic glycolysis implicated HSF2 in metabolic reprogramming supporting HCC proliferation.","evidence":"Co-IP, siRNA, ChIP, proliferation and glycolysis assays","pmids":["31497345"],"confidence":"Medium","gaps":["Direct HSF2 binding to FBP1 locus versus EHMT2 recruitment not fully separated","Single lab"]},{"year":2020,"claim":"Identifying HSF1-driven de novo HSF2 transcription during proteasome inhibition explained how HSF2 is induced and contributes to cancer cell migration under proteotoxic stress.","evidence":"ChIP, EMSA, reporter assay, RT-PCR, immunofluorescence, migration assay","pmids":["32607595"],"confidence":"Medium","gaps":["Migration mechanism downstream of HSF2 not detailed","Single lab"]},{"year":2021,"claim":"Demonstrating HSF2 binds ATP-bound HSP90 like HSF1 placed HSF2 within chaperone-mediated regulation of the heat shock response.","evidence":"Co-IP with HSP90 mutants in HSF1/HSF2 KO cells","pmids":["34331200"],"confidence":"Medium","gaps":["Functional consequence of HSP90-HSF2 binding for HSF2 activity unclear","Stress response shown HSF1-dependent, HSF2 role secondary"]},{"year":2022,"claim":"Acetylation/deacetylation control and shared genome-wide co-occupancy with HSF1 established a stability-and-chromatin axis for HSF2 in neurodevelopment and cancer.","evidence":"Co-IP and acetylation assays with patient-derived organoids (CBP/EP300); ChIP-seq, Co-IP and xenografts (HSF1-HSF2 co-regulation)","pmids":["36385105","35294249"],"confidence":"High","gaps":["Distinguishing HSF2-unique from HSF1-driven occupancy incomplete","CBP/EP300-HSF2-N-cadherin cascade mechanism partial"]},{"year":2025,"claim":"HDAC1-driven destabilization and TGF-β-mediated downregulation defined HSF2 as a tightly degradation-controlled, stage-specific switch between proliferation and invasion.","evidence":"Unbiased Co-IP screen, catalytic mutant and ubiquitination assays, tissue IHC (HDAC1); cell and zebrafish xenograft models with ectopic expression (TGF-β/EMT)","pmids":["40318841","40901953"],"confidence":"High","gaps":["E3 ligase mediating HDAC1-coupled ubiquitination not identified","TGF-β regulation of HSF2 transcription versus stability not fully separated"]},{"year":2026,"claim":"Defining an HSF2-HSP110 axis supporting RNA Pol II processivity and CTD Ser7 phosphorylation established HSF2 as a guardian of genome stability whose loss promotes tumorigenesis.","evidence":"HSF2/HSP110 KO cells, irradiation assays, Pol II ChIP, CTD phosphorylation Westerns, splicing analysis, in vivo lymphoma model","pmids":["41995727"],"confidence":"High","gaps":["Direct molecular step from HSF2 to CTD Ser7 kinase activity not defined","Whether transcription-factor versus chaperone-cofactor role dominates unresolved"]},{"year":null,"claim":"How HSF2's paralog-specific transcriptional outputs, modification states, and partner choices are coordinated to switch between Hsp regulation, developmental programs, metabolic reprogramming and genome maintenance remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking HSF2 PTM state to target gene selection","The E3 ligase(s) and full degron controlling HSF2 turnover are unidentified","Direct versus chaperone-cofactor contributions to Pol II regulation not separated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,8,9,12,17,27]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,1,8,19]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,6,17,20,24]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[10,17]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,8,9,27]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[3,8,17]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[10,14,17]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[5,7,12,26]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[16,26,27,30]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[3,26,28]}],"complexes":["HSF1-HSF2 heterotrimer"],"partners":["HSF1","HSF4","HSP90","HSP110","CREBBP","EP300","HDAC1","UBC9"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q03933","full_name":"Heat shock factor protein 2","aliases":["Heat shock transcription factor 2","HSTF 2"],"length_aa":536,"mass_kda":60.3,"function":"DNA-binding protein that specifically binds heat shock promoter elements (HSE) and activates transcription. In higher eukaryotes, HSF is unable to bind to the HSE unless the cells are heat shocked","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q03933/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HSF2","classification":"Not Classified","n_dependent_lines":12,"n_total_lines":1208,"dependency_fraction":0.009933774834437087},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"HSF1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/HSF2","total_profiled":1310},"omim":[{"mim_id":"608829","title":"SMALL UBIQUITIN-LIKE MODIFIER 4; SUMO4","url":"https://www.omim.org/entry/608829"},{"mim_id":"606280","title":"NON-SMC CONDENSIN I COMPLEX SUBUNIT G; NCAPG","url":"https://www.omim.org/entry/606280"},{"mim_id":"605554","title":"CD244 ANTIGEN; CD244","url":"https://www.omim.org/entry/605554"},{"mim_id":"604572","title":"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 1; DNAJB1","url":"https://www.omim.org/entry/604572"},{"mim_id":"604554","title":"HEAT-SHOCK TRANSCRIPTION FACTOR 2-BINDING PROTEIN; HSF2BP","url":"https://www.omim.org/entry/604554"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/HSF2"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q03933","domains":[{"cath_id":"1.10.10.10","chopping":"8-105","consensus_level":"high","plddt":88.8595,"start":8,"end":105},{"cath_id":"1.20.5","chopping":"123-183","consensus_level":"medium","plddt":91.8918,"start":123,"end":183}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q03933","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q03933-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q03933-F1-predicted_aligned_error_v6.png","plddt_mean":59.47},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HSF2","jax_strain_url":"https://www.jax.org/strain/search?query=HSF2"},"sequence":{"accession":"Q03933","fasta_url":"https://rest.uniprot.org/uniprotkb/Q03933.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q03933/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q03933"}},"corpus_meta":[{"pmid":"1871106","id":"PMC_1871106","title":"Isolation of a cDNA for HSF2: evidence for two heat shock factor genes in humans.","date":"1991","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1871106","citation_count":290,"is_preprint":false},{"pmid":"17213196","id":"PMC_17213196","title":"Heat shock factor 2 (HSF2) contributes to inducible expression of hsp genes through interplay with HSF1.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17213196","citation_count":175,"is_preprint":false},{"pmid":"9710593","id":"PMC_9710593","title":"Heat shock response and protein degradation: regulation of HSF2 by the ubiquitin-proteasome pathway.","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9710593","citation_count":174,"is_preprint":false},{"pmid":"12032072","id":"PMC_12032072","title":"Brain abnormalities, defective meiotic chromosome synapsis and female subfertility in HSF2 null mice.","date":"2002","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12032072","citation_count":148,"is_preprint":false},{"pmid":"7935474","id":"PMC_7935474","title":"Selection of new HSF1 and HSF2 DNA-binding sites reveals difference in trimer cooperativity.","date":"1994","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7935474","citation_count":120,"is_preprint":false},{"pmid":"12748967","id":"PMC_12748967","title":"Targeted disruption of the heat shock transcription factor (hsf)-2 gene results in increased embryonic lethality, neuronal defects, and reduced spermatogenesis.","date":"2003","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/12748967","citation_count":120,"is_preprint":false},{"pmid":"16336210","id":"PMC_16336210","title":"Up-regulation of the clusterin gene after proteotoxic stress: implication of HSF1-HSF2 heterocomplexes.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16336210","citation_count":104,"is_preprint":false},{"pmid":"14994269","id":"PMC_14994269","title":"Essential requirement for both hsf1 and hsf2 transcriptional activity in spermatogenesis and male fertility.","date":"2004","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/14994269","citation_count":95,"is_preprint":false},{"pmid":"12865437","id":"PMC_12865437","title":"Formation of nuclear stress granules involves HSF2 and coincides with the nucleolar localization of Hsp70.","date":"2003","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/12865437","citation_count":92,"is_preprint":false},{"pmid":"26727490","id":"PMC_26727490","title":"Structures of HSF2 reveal mechanisms for differential regulation of human heat-shock factors.","date":"2016","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/26727490","citation_count":70,"is_preprint":false},{"pmid":"8035809","id":"PMC_8035809","title":"Characterization of constitutive HSF2 DNA-binding activity in mouse embryonal carcinoma cells.","date":"1994","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8035809","citation_count":67,"is_preprint":false},{"pmid":"18682557","id":"PMC_18682557","title":"Promoter ChIP-chip analysis in mouse testis reveals Y chromosome occupancy by HSF2.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18682557","citation_count":62,"is_preprint":false},{"pmid":"17915561","id":"PMC_17915561","title":"HSF2 binds to the Hsp90, Hsp27, and c-Fos promoters constitutively and modulates their expression.","date":"2007","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/17915561","citation_count":51,"is_preprint":false},{"pmid":"23064888","id":"PMC_23064888","title":"A dominant-negative mutation of HSF2 associated with idiopathic azoospermia.","date":"2012","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23064888","citation_count":50,"is_preprint":false},{"pmid":"28295305","id":"PMC_28295305","title":"Mitochondrial ROS-induced ERK1/2 activation and HSF2-mediated AT1 R upregulation are required for doxorubicin-induced cardiotoxicity.","date":"2017","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/28295305","citation_count":46,"is_preprint":false},{"pmid":"21258402","id":"PMC_21258402","title":"Regulation of transcription of hypoxia-inducible factor-1α (HIF-1α) by heat shock factors HSF2 and HSF4.","date":"2011","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/21258402","citation_count":45,"is_preprint":false},{"pmid":"25202032","id":"PMC_25202032","title":"Expression of HSF2 decreases in mitosis to enable stress-inducible transcription and cell survival.","date":"2014","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/25202032","citation_count":37,"is_preprint":false},{"pmid":"28796250","id":"PMC_28796250","title":"p53-mediated miR-18 repression activates HSF2 for IGF-IIR-dependent myocyte hypertrophy in hypertension-induced heart failure.","date":"2017","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/28796250","citation_count":36,"is_preprint":false},{"pmid":"10064819","id":"PMC_10064819","title":"Cellular localization of the heat shock transcription factors HSF1 and HSF2 in the rat brain during postnatal development and following hyperthermia.","date":"1999","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/10064819","citation_count":36,"is_preprint":false},{"pmid":"35294249","id":"PMC_35294249","title":"HSF2 cooperates with HSF1 to drive a transcriptional program critical for the malignant state.","date":"2022","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/35294249","citation_count":31,"is_preprint":false},{"pmid":"31497345","id":"PMC_31497345","title":"HSF2 regulates aerobic glycolysis by suppression of FBP1 in hepatocellular carcinoma.","date":"2019","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/31497345","citation_count":26,"is_preprint":false},{"pmid":"28277193","id":"PMC_28277193","title":"miR-202 Promotes Cell Apoptosis in Esophageal Squamous Cell Carcinoma by Targeting HSF2.","date":"2017","source":"Oncology research","url":"https://pubmed.ncbi.nlm.nih.gov/28277193","citation_count":24,"is_preprint":false},{"pmid":"29180262","id":"PMC_29180262","title":"Inhibition of HSF2 SUMOylation via MEL18 upregulates IGF-IIR and leads to hypertension-induced cardiac hypertrophy.","date":"2017","source":"International journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/29180262","citation_count":24,"is_preprint":false},{"pmid":"10561509","id":"PMC_10561509","title":"Transcriptional activation of mouse cytosolic chaperonin CCT subunit genes by heat shock factors HSF1 and HSF2.","date":"1999","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10561509","citation_count":24,"is_preprint":false},{"pmid":"32607595","id":"PMC_32607595","title":"The proteostasis guardian HSF1 directs the transcription of its paralog and interactor HSF2 during proteasome dysfunction.","date":"2020","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/32607595","citation_count":22,"is_preprint":false},{"pmid":"18211895","id":"PMC_18211895","title":"MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18211895","citation_count":20,"is_preprint":false},{"pmid":"20538055","id":"PMC_20538055","title":"Analysis of the Wnt/B-catenin/TCF4 pathway using SAGE, genome-wide microarray and promoter analysis: Identification of BRI3 and HSF2 as novel targets.","date":"2010","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/20538055","citation_count":19,"is_preprint":false},{"pmid":"36385105","id":"PMC_36385105","title":"CBP-HSF2 structural and functional interplay in Rubinstein-Taybi neurodevelopmental disorder.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36385105","citation_count":17,"is_preprint":false},{"pmid":"18434628","id":"PMC_18434628","title":"Interaction of HSF1 and HSF2 with the Hspa1b promoter in mouse epididymal spermatozoa.","date":"2008","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/18434628","citation_count":17,"is_preprint":false},{"pmid":"34331200","id":"PMC_34331200","title":"Gambogic acid and gambogenic acid induce a thiol-dependent heat shock response and disrupt the interaction between HSP90 and HSF1 or HSF2.","date":"2021","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/34331200","citation_count":17,"is_preprint":false},{"pmid":"36167792","id":"PMC_36167792","title":"HSF2BP protects against acute liver injury by regulating HSF2/HSP70/MAPK signaling in mice.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/36167792","citation_count":15,"is_preprint":false},{"pmid":"18586951","id":"PMC_18586951","title":"Neurospora crassa heat shock factor 1 Is an essential gene; a second heat shock factor-like gene, hsf2, is required for asexual spore formation.","date":"2008","source":"Eukaryotic cell","url":"https://pubmed.ncbi.nlm.nih.gov/18586951","citation_count":15,"is_preprint":false},{"pmid":"21480429","id":"PMC_21480429","title":"Expression of Hsf1, Hsf2, and Phlda1 in cells undergoing cryptorchid-induced apoptosis in rat testes.","date":"2011","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/21480429","citation_count":14,"is_preprint":false},{"pmid":"10872807","id":"PMC_10872807","title":"Molecular basis of competition between HSF2 and catalytic subunit for binding to the PR65/A subunit of PP2A.","date":"2000","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10872807","citation_count":13,"is_preprint":false},{"pmid":"30849975","id":"PMC_30849975","title":"Basal and dynamics mRNA expression of muscular HSP108, HSP90, HSF-1 and HSF-2 in thermally manipulated broilers during embryogenesis.","date":"2019","source":"BMC veterinary research","url":"https://pubmed.ncbi.nlm.nih.gov/30849975","citation_count":13,"is_preprint":false},{"pmid":"34634367","id":"PMC_34634367","title":"Aqueous extract of Solanum nigrum attenuates Angiotensin-II induced cardiac hypertrophy and improves cardiac function by repressing protein kinase C-ζ to restore HSF2 deSUMOlyation and Mel-18-IGF-IIR signaling suppression.","date":"2021","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34634367","citation_count":12,"is_preprint":false},{"pmid":"16938384","id":"PMC_16938384","title":"Cloning of zebrafish (Danio rerio) heat shock factor 2 (HSF2) and similar patterns of HSF2 and HSF1 mRNA expression in brain tissues.","date":"2006","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/16938384","citation_count":12,"is_preprint":false},{"pmid":"38458311","id":"PMC_38458311","title":"Comprehensive analysis of human tissues reveals unique expression and localization patterns of HSF1 and HSF2.","date":"2024","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/38458311","citation_count":11,"is_preprint":false},{"pmid":"21792930","id":"PMC_21792930","title":"Heat shock factor 4a (HSF4a) represses HSF2 expression and HSF2-mediated transcriptional activity.","date":"2012","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21792930","citation_count":10,"is_preprint":false},{"pmid":"12527426","id":"PMC_12527426","title":"Cloning and characterization of the rat Hsf2 promoter: a critical role of proximal E-box element and USF protein in Hsf2 regulation in different compartments of the brain.","date":"2003","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/12527426","citation_count":10,"is_preprint":false},{"pmid":"10333528","id":"PMC_10333528","title":"Genomic structure and chromosomal localization of the mouse Hsf2 gene and promoter sequences.","date":"1999","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10333528","citation_count":10,"is_preprint":false},{"pmid":"18570919","id":"PMC_18570919","title":"PRC1 associates with the hsp70i promoter and interacts with HSF2 during mitosis.","date":"2008","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/18570919","citation_count":9,"is_preprint":false},{"pmid":"33456524","id":"PMC_33456524","title":"DUOX2 participates in skin aging induced by UVB in HSF2 cells by activating NF-κB signaling.","date":"2020","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33456524","citation_count":7,"is_preprint":false},{"pmid":"29270451","id":"PMC_29270451","title":"Data supporting the angiotensin II activates MEL18 to deSUMOylate HSF2 for hypertension-related heart failure.","date":"2017","source":"Data in brief","url":"https://pubmed.ncbi.nlm.nih.gov/29270451","citation_count":7,"is_preprint":false},{"pmid":"40901953","id":"PMC_40901953","title":"HSF2 drives breast cancer progression by acting as a stage-specific switch between proliferation and invasion.","date":"2025","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/40901953","citation_count":5,"is_preprint":false},{"pmid":"35182974","id":"PMC_35182974","title":"Heat shock transcription factor HSF2 modulates the autophagy response through the BTG2-SOD2 axis.","date":"2022","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/35182974","citation_count":5,"is_preprint":false},{"pmid":"38791628","id":"PMC_38791628","title":"The Expression and Epigenetic Characteristics of the HSF2 Gene in Cattle-Yak and the Correlation with Its Male Sterility.","date":"2024","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/38791628","citation_count":4,"is_preprint":false},{"pmid":"36964632","id":"PMC_36964632","title":"Overexpression of HSF2 binding protein suppresses endoplasmic reticulum stress via regulating subcellular localization of CDC73 in hepatocytes.","date":"2023","source":"Cell & bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/36964632","citation_count":4,"is_preprint":false},{"pmid":"38641046","id":"PMC_38641046","title":"Hsf1 and Hsf2 in normal, healthy human tissues: Immunohistochemistry provokes new questions.","date":"2024","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/38641046","citation_count":3,"is_preprint":false},{"pmid":"26260034","id":"PMC_26260034","title":"HSF2 autoregulates its own transcription.","date":"2015","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26260034","citation_count":3,"is_preprint":false},{"pmid":"37735976","id":"PMC_37735976","title":"Genome-wide association study reveals HSF2, GJA1 and TRIM36 as susceptibility genes for preeclampsia: a community-based population study in Tianjin, China.","date":"2023","source":"Hypertension in pregnancy","url":"https://pubmed.ncbi.nlm.nih.gov/37735976","citation_count":3,"is_preprint":false},{"pmid":"40318841","id":"PMC_40318841","title":"HDAC1 is involved in the destabilization of the HSF2 protein under nonstress and stress conditions.","date":"2025","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/40318841","citation_count":2,"is_preprint":false},{"pmid":"35540693","id":"PMC_35540693","title":"Male infertility is not liked with HSF1, HSF2 and UBE2I gene polymorphisms among Indian subjects.","date":"2021","source":"Bioinformation","url":"https://pubmed.ncbi.nlm.nih.gov/35540693","citation_count":1,"is_preprint":false},{"pmid":"41995727","id":"PMC_41995727","title":"HSF2-HSP110 axis supports genome stability via RNA polymerase II transcription and DNA repair.","date":"2026","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/41995727","citation_count":0,"is_preprint":false},{"pmid":"41613802","id":"PMC_41613802","title":"Retraction: miR-202 Promotes Cell Apoptosis in Esophageal Squamous Cell Carcinoma by Targeting HSF2.","date":"2026","source":"Oncology research","url":"https://pubmed.ncbi.nlm.nih.gov/41613802","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.06.24.600354","title":"Dynamic HSF2 regulation drives breast cancer progression by steering the balance between proliferation and invasion","date":"2024-06-24","source":"bioRxiv","url":"https://doi.org/10.1101/2024.06.24.600354","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":27320,"output_tokens":7109,"usd":0.094298,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16419,"output_tokens":6796,"usd":0.125998,"stage2_stop_reason":"end_turn"},"total_usd":0.220296,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1991,\n      \"finding\": \"HSF2 encodes a protein that binds heat shock elements (HSEs) with specificity identical to HeLa HSF and stimulates transcription from a heat shock promoter, establishing it as a distinct human heat shock transcription factor paralog separate from HSF1.\",\n      \"method\": \"cDNA cloning, in vitro DNA-binding assay, transcriptional reporter assay, antibody cross-reactivity\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct biochemical reconstitution (DNA binding, transcriptional activation) with multiple orthogonal methods in founding paper\",\n      \"pmids\": [\"1871106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"HSF2 forms trimers and binds HSEs composed of alternating inverted pentameric nGAAn repeats, but exhibits less cooperative DNA binding than HSF1; sequences within or adjacent to the HSF1 DNA-binding domain (not shared by HSF2) confer the higher cooperativity to HSF1, as demonstrated by chimeric HSF1/HSF2 proteins.\",\n      \"method\": \"In vitro DNA-binding selection (SELEX), mutagenesis of HSEs, chimeric protein analysis, gel-shift assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with mutagenesis and chimeric protein analysis, multiple orthogonal methods\",\n      \"pmids\": [\"7935474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"HSF2 is present as a trimer in mouse embryonal carcinoma (EC) cells and exhibits constitutive HSE-binding activity, but trimerization and nuclear localization of HSF2 are not sufficient for in vivo binding to the hsp70 HSE in unstressed EC cells, and HSF2 does not stimulate hsp70 or hsp86 transcription under these conditions.\",\n      \"method\": \"Gel-shift assay, transcription run-on assay, genomic footprinting, immunoblotting\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (gel shift, genomic footprinting, run-on transcription) in single rigorous study\",\n      \"pmids\": [\"8035809\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"HSF2 activation is triggered by inhibition of the ubiquitin-proteasome pathway; HSF2 is a labile protein whose activation requires both continued protein synthesis and reduced proteasomal degradation, establishing proteasome dysfunction as a stress signal for HSF2.\",\n      \"method\": \"Proteasome inhibitor treatment (hemin, MG132, lactacystin), ts85 cell line (E1 ubiquitin-activating enzyme mutant), DNA-binding assays, immunoblotting\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple inhibitors and genetic model (ts85) converge on same conclusion, replicated across conditions\",\n      \"pmids\": [\"9710593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"HSF2 physically interacts with the PR65/A scaffolding subunit of PP2A and competes with the PP2A catalytic subunit for binding; this competition maps to lysine 416 within the intra-repeat loop of HEAT repeat 11 of PR65, shared by both HSF2 and the catalytic subunit binding interface.\",\n      \"method\": \"Co-immunoprecipitation, pulldown with point mutants of PR65\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal binding with mutagenesis mapping, single lab\",\n      \"pmids\": [\"10872807\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"HSF2-null mice exhibit brain abnormalities (enlarged lateral and third ventricles, reduced hippocampus and striatum), meiotic defects in spermatogenesis (apoptosis of spermatocytes, synaptonemal complex structural defects), and female subfertility, demonstrating essential roles in brain development and gametogenesis.\",\n      \"method\": \"Targeted gene disruption (knockout mouse), histology, immunohistochemistry\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic KO with defined phenotypic readouts, independently replicated by a second group (PMID 12748967)\",\n      \"pmids\": [\"12032072\", \"12748967\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"HSF2 physically interacts with HSF1 and localizes to nuclear stress granules upon heat shock; deletion mutant analysis shows HSF2 influences HSF1 localization to stress granules; stress granule dynamics coincide with nucleolar Hsp70 accumulation.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence, deletion mutant analysis, live-cell imaging\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP and deletion mutants in single lab, two orthogonal methods\",\n      \"pmids\": [\"12865437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Genetic disruption of both hsf1 and hsf2 causes male sterility with more severe spermatogenesis defects than either single knockout alone, including failure of germ cells to progress past pachytene and loss of transcription of spermatogenesis-specific genes, demonstrating additive/synergistic transcriptional roles in spermatogenesis.\",\n      \"method\": \"Double-knockout mouse genetics, histology, RT-PCR\",\n      \"journal\": \"Genesis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — double KO genetic epistasis with defined cellular and molecular phenotype\",\n      \"pmids\": [\"14994269\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Upon proteasome inhibition, HSF1 and HSF2 form heterocomplexes that bind to the clusterin heat shock element (CLE) and activate clusterin transcription; gel-filtration indicates these heterocomplexes have the same apparent mass as HSF1 homotrimers, suggesting HSF1-HSF2 heterotrimer formation.\",\n      \"method\": \"Gel mobility-shift assay, supershift assay, chromatin immunoprecipitation (ChIP), co-immunoprecipitation, gel-filtration analysis, promoter deletion/mutation studies\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal methods (gel shift, supershift, ChIP, co-IP, gel filtration) in single study\",\n      \"pmids\": [\"16336210\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"HSF2 participates in heat-shock-inducible hsp70 promoter occupancy and modulates HSF1-mediated Hsp gene expression; intact HSF1 is required for maximal HSF2 promoter occupancy, indicating HSF1 influences HSF2 DNA-binding activity at the hsp70 promoter.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), real-time RT-PCR, HSF2 knockdown/overexpression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP on chromatin with quantitative expression analysis, two orthogonal methods, single lab\",\n      \"pmids\": [\"17213196\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"HSF2 binds constitutively to HSE elements in the Hsp90, Hsp27, and c-Fos promoters during mitosis (gene bookmarking); RNAi-mediated reduction of HSF2 leads to decreased protein levels of Hsp90, Hsp27, and c-Fos, establishing HSF2 as required for their expression.\",\n      \"method\": \"Chromatin immunoprecipitation, RNA interference (RNAi), immunoblotting\",\n      \"journal\": \"Cell stress & chaperones\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus RNAi with protein-level readout, single lab\",\n      \"pmids\": [\"17915561\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"HSF2 interacts with the polycomb protein MEL-18 and the SUMO E2 enzyme UBC9; MEL-18 binding to HSF2 inhibits HSF2 sumoylation by blocking UBC9 activity; this interaction decreases during mitosis, explaining the observed increase in HSF2 sumoylation during mitosis.\",\n      \"method\": \"Co-immunoprecipitation, RNA interference, overexpression, sumoylation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP with RNAi and overexpression validation, single lab\",\n      \"pmids\": [\"18211895\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"HSF2 occupies Y chromosome MSYq gene promoters in mouse testis in vivo; HSF2 disruption causes reduced expression of MSYq-resident multicopy genes, sperm head abnormalities, altered chromatin packing proteins, and increased sperm DNA fragmentation, defining HSF2 as a regulator of Y-chromosome gene transcription required for correct chromatin organization in sperm.\",\n      \"method\": \"ChIP-chip (promoter microarray), Hsf2 knockout mouse, RT-PCR, immunofluorescence, TUNEL assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide ChIP-chip plus KO mouse with molecular and cellular phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"18682557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"HSF1 and HSF2 are both bound to the Hspa1b (hsp70.1) promoter in epididymal spermatozoa (gene bookmarking), with HSF2 binding increasing from early to late spermatids, suggesting a mechanism for rapid transcription-competence during zygotic genome activation after fertilization.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), Western blot, immunofluorescence\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP in primary cells with staged analysis, single lab\",\n      \"pmids\": [\"18434628\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"HSF2 directly interacts with PRC1 (Protein Regulating Cytokinesis 1) specifically during mitosis; PRC1 co-localizes with HSF2 during mitosis and is associated with the hsp70i promoter during this phase, suggesting HSF2-PRC1 interaction provides a mechanistic basis for the cytokinesis defects observed in HSF2-null cells.\",\n      \"method\": \"Co-immunoprecipitation, co-localization by immunofluorescence, chromatin immunoprecipitation\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP with ChIP and co-localization, specificity confirmed (HSF1 does not interact), single lab\",\n      \"pmids\": [\"18570919\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"HSF2 and HSF4 both bind to discontinuous HSE sequences in the HIF-1α promoter and cooperate to maintain HIF-1α transcription in a repressed state; downregulation of either HSF activates HIF-1α transcription, and overexpression of either displaces the other from the promoter, showing a competitive balance is required.\",\n      \"method\": \"Genome-wide EST screen, ChIP, promoter reporter assay, siRNA knockdown, overexpression\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus reporter assay plus knockdown/overexpression, multiple methods, single lab\",\n      \"pmids\": [\"21258402\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"A heterozygous missense mutation R502H in human HSF2 causes complete loss of HSF2 transcriptional function and suppresses wild-type HSF2 function through a dominant-negative mechanism, establishing a link between HSF2 loss-of-function and idiopathic azoospermia.\",\n      \"method\": \"Sequencing of patient cohort, functional transcriptional assay of mutant vs. wild-type HSF2\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional assay in human patient-derived mutation, single lab\",\n      \"pmids\": [\"23064888\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"HSF2 expression declines during mitosis, and this decline allows HSF1 and RNA polymerase II to access condensed chromatin for stress-inducible Hsp expression; HSF2-deficient cells show reduced mitotic errors and improved survival upon acute stress, demonstrating that HSF2 normally restricts stress-inducible transcription during mitosis.\",\n      \"method\": \"HSF2 knockout/knockdown cells, immunofluorescence, ChIP, flow cytometry (mitotic errors, apoptosis), RT-PCR\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with multiple orthogonal readouts (ChIP, transcription, mitotic errors, survival) in single rigorous study\",\n      \"pmids\": [\"25202032\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HSF2 negatively autoregulates its own transcription by binding to an HSE in its own promoter (~1.5 kb downstream of TSS), forming a negative autoregulatory loop.\",\n      \"method\": \"Luciferase reporter assay, ChIP, RT-PCR after HSF2 transfection\",\n      \"journal\": \"International journal of molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus reporter assay plus endogenous mRNA readout, single lab\",\n      \"pmids\": [\"26260034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Crystal structures of the human HSF2 DNA-binding domain (DBD) bound to DNA reveal a C-terminal helix that directs wrapping of the coiled-coil domain around DNA, exposing paralog-specific DBD surface sequences for differential post-translational modifications and cofactor interactions; a direct interaction between HSF1 and HSF2 through their coiled-coil domains was also demonstrated.\",\n      \"method\": \"X-ray crystallography, co-immunoprecipitation of HSF1-HSF2 coiled-coil interaction\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with functional validation (Co-IP of coiled-coil interaction), single rigorous study\",\n      \"pmids\": [\"26727490\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"DOX-induced mitochondrial ROS activate ERK1/2, which promotes HSF2 nuclear translocation and deSUMOylation, leading to HSF2 binding to the AT1R promoter and upregulating AT1R expression, contributing to cardiomyocyte apoptosis and cardiotoxicity.\",\n      \"method\": \"Immunofluorescence (nuclear translocation), DNA-binding assay, siRNA knockdown, overexpression, in vitro and in vivo cardiomyocyte models\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — nuclear translocation, DNA binding, and functional apoptosis readout linked, single lab\",\n      \"pmids\": [\"28295305\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MEL18 inhibits SUMO-1-mediated SUMOylation of HSF2 (specifically at lysine 82) by interacting with UBC9 and blocking its activity; loss of HSF2 SUMOylation activates IGF-IIR transcription and induces cardiac hypertrophy; angiotensin II receptor blockade restores HSF2 SUMOylation.\",\n      \"method\": \"Co-immunoprecipitation, SUMOylation assay, site-directed mutagenesis (K82), Western blot, in vivo spontaneously hypertensive rat model\",\n      \"journal\": \"International journal of cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — SUMOylation site mapping with mutagenesis plus in vivo validation, single lab\",\n      \"pmids\": [\"29180262\", \"29270451\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"p53 activation by angiotensin II represses miR-18, which de-represses HSF2 expression; elevated HSF2 then activates IGF-IIR transcription, inducing cardiomyocyte hypertrophy; cardiac-specific miR-18 overexpression protects against hypertension-induced heart failure.\",\n      \"method\": \"miRNA target site validation (3'-UTR luciferase), adenovirus-AAV gene transfer, in vitro NRVM model, in vivo transgenic overexpression\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — 3'-UTR reporter assay plus in vivo genetic model, single lab\",\n      \"pmids\": [\"28796250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HSF2 interacts with EHMT2 (G9a histone methyltransferase) to epigenetically silence FBP1 via histone methylation, thereby promoting aerobic glycolysis (Warburg effect) and HCC cell proliferation.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, ChIP, proliferation and glycolysis assays\",\n      \"journal\": \"American journal of cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and ChIP with functional readout, single lab\",\n      \"pmids\": [\"31497345\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"HSF1 directly binds an HSE located 1,397 bp upstream of the HSF2 transcription start site in the HSF2 promoter and drives de novo HSF2 mRNA transcription during proteasome inhibition (bortezomib treatment); bortezomib-induced HSF2 localizes in the nucleus, interacts with HSF1, and participates in cancer cell migration.\",\n      \"method\": \"Chromatin immunoprecipitation, EMSA, promoter-reporter assay, RT-PCR, immunofluorescence, migration assay\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP, EMSA, and reporter assay converge on HSF1 binding to HSF2 promoter, single lab\",\n      \"pmids\": [\"32607595\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Endogenous HSF2 co-precipitates with ATP-bound (closed-form) HSP90, mirroring HSF1's known interaction with HSP90; treatment with gambogic acid or gambogenic acid disrupts both HSP90-HSF1 and HSP90-HSF2 interactions and induces a thiol-dependent heat shock response that is HSF1-dependent.\",\n      \"method\": \"Co-immunoprecipitation with HSP90 mutants, HSF1/HSF2 knockout cells, immunoblotting\",\n      \"journal\": \"Cell stress & chaperones\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with KO validation and HSP90 mutants, single lab\",\n      \"pmids\": [\"34331200\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CBP/EP300 acetyltransferases directly interact with HSF2 and acetylate it, leading to HSF2 protein stabilization; loss of CBP/EP300 function (as in Rubinstein-Taybi syndrome) reduces HSF2 levels and disrupts a CBP/EP300-HSF2-N-cadherin cascade required for neuroepithelial integrity in cerebral organoids.\",\n      \"method\": \"Co-immunoprecipitation, acetylation assay, patient-derived iPSC organoids, 2D/3D cellular models, Western blot\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — acetylation biochemistry plus patient-derived cell models plus organoid phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"36385105\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"HSF2 physically and functionally interacts with HSF1 across diverse cancer types; HSF1 and HSF2 share notably similar chromatin occupancy and co-regulate a common set of target genes (including HSPs and non-canonical cancer-supporting genes); loss of HSF2 impairs response to nutrient stress and reduces tumor progression in xenografts.\",\n      \"method\": \"Co-immunoprecipitation, ChIP-seq, xenograft tumor models, CRISPR/siRNA loss-of-function\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-seq plus Co-IP plus in vivo xenograft, multiple orthogonal methods\",\n      \"pmids\": [\"35294249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"HDAC1 interacts with HSF2 and destabilizes the HSF2 protein through its catalytic deacetylase activity, driving HSF2 poly-ubiquitination and proteasomal degradation under both normal and stress conditions; HDAC1 and HSF2 co-localize in developing mouse cortex and human cerebral organoids.\",\n      \"method\": \"Unbiased co-immunoprecipitation screen, catalytic mutant analysis, ubiquitination assay, proteasome inhibitor rescue, immunohistochemistry in mouse cortex and human organoids\",\n      \"journal\": \"Cell stress & chaperones\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — unbiased screen with mechanistic follow-up (catalytic mutant, ubiquitination), in vivo tissue validation, single lab\",\n      \"pmids\": [\"40318841\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TGF-β signaling downregulates HSF2 expression to enable acquisition of an invasive phenotype in breast cancer; ectopic HSF2 expression inhibits TGF-β-mediated EMT gene expression and invasive properties; temporal HSF2 downregulation is required for EMT activation, while sustained HSF2 promotes proliferation over invasion.\",\n      \"method\": \"Cell-based models, in vivo zebrafish xenografts, ectopic expression, human patient tissue analysis (IHC), RT-PCR\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo (zebrafish) models with ectopic expression rescue and human tissue correlation, single lab\",\n      \"pmids\": [\"40901953\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"HSF2 forms a genotoxic stress-responsive axis with its client chaperone HSP110; HSF2 loss increases DNA damage and IR sensitivity by impairing RNA Pol II processivity and CTD phosphorylation at serine 7, leading to transcriptional dysregulation, replication conflicts, altered pre-mRNA splicing, and reduced DNA repair gene expression; in vivo, HSF2 loss accelerates IR-induced T cell lymphoma.\",\n      \"method\": \"HSF2/HSP110 knockout cells, irradiation assays, RNA Pol II ChIP, CTD phosphorylation assays (Western blot), pre-mRNA splicing analysis, in vivo mouse lymphoma model\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with multiple molecular readouts (ChIP, phosphorylation, splicing) plus in vivo tumor model, single rigorous study\",\n      \"pmids\": [\"41995727\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HSF2 is a stress-responsive and developmentally regulated transcription factor that binds HSEs as trimers with lower cooperativity than HSF1; it physically interacts with HSF1 through coiled-coil domains (structurally defined by crystal structures) to form heterocomplexes that co-occupy promoters and co-regulate Hsp and non-canonical target genes in stress responses, development, cancer, and genome maintenance; its activity is modulated by ubiquitin-proteasome-dependent protein stability, SUMO-1 conjugation (regulated by MEL18/UBC9), acetylation-mediated stabilization by CBP/EP300 (countered by HDAC1-driven destabilization), nuclear translocation downstream of ERK1/2 and ROS, interaction with HSP90, HSF4, PRC1, and PP2A-PR65; HSF2 is essential for spermatogenesis, brain development, MSYq gene regulation in sperm, and genome stability via a HSF2-HSP110-RNA Pol II axis, and it acts as a stage-specific switch between proliferation and invasion in cancer through TGF-β-mediated regulation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"HSF2 is a stress-responsive and developmentally regulated transcription factor that binds heat shock elements (HSEs) as trimers and stimulates transcription from heat shock promoters [#0, #1]. It binds inverted nGAAn pentameric repeats with lower cooperativity than its paralog HSF1, a difference traced to HSF1-specific sequences in/around the DNA-binding domain [#1], and crystal structures of the HSF2 DBD–DNA complex show a C-terminal helix that wraps the coiled-coil around DNA and exposes paralog-specific surfaces for differential modification and cofactor binding [#19]. A central feature of HSF2 biology is its physical and functional partnership with HSF1: the two interact through their coiled-coil domains [#19], form heterotrimeric complexes that bind composite HSEs (e.g. the clusterin CLE) and co-occupy promoters [#8, #9], and share extensive chromatin occupancy to co-regulate Hsp and non-canonical target genes in stress and cancer [#27]. HSF2 acts in gene bookmarking, binding HSE-containing promoters (Hsp90, Hsp27, c-Fos, hsp70) during mitosis, and its level must decline in mitosis to permit HSF1/RNA Pol II access to condensed chromatin for stress-inducible transcription [#10, #17]. HSF2 is a short-lived protein whose abundance and activity are set by proteostasis and post-translational modification: proteasome inhibition activates it [#3], CBP/EP300-mediated acetylation stabilizes it while HDAC1-driven deacetylation promotes its poly-ubiquitination and degradation [#26, #28], and SUMOylation at K82 (controlled by MEL18 blockade of UBC9) modulates its target output [#11, #21]. Developmentally, HSF2 is essential for spermatogenesis and brain development: knockout mice show meiotic and synaptonemal defects and brain abnormalities [#5], it occupies and regulates Y-chromosome MSYq multicopy genes required for proper sperm chromatin [#12], and a dominant-negative R502H mutation links HSF2 loss-of-function to idiopathic azoospermia [#16]. In cancer it functions as a stage-specific switch, with TGF-β-driven downregulation enabling EMT and invasion while sustained expression favors proliferation [#29], and it maintains genome stability through an HSF2–HSP110 axis that supports RNA Pol II processivity and CTD serine-7 phosphorylation, with HSF2 loss accelerating irradiation-induced lymphoma [#30].\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"Establishing that a distinct human gene encodes an HSE-binding transcriptional activator defined HSF2 as a heat-shock transcription factor separate from HSF1.\",\n      \"evidence\": \"cDNA cloning with in vitro DNA-binding and reporter assays\",\n      \"pmids\": [\"1871106\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish physiological conditions of activation\", \"No distinction of HSF2-specific versus HSF1-shared targets\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Defining HSF2 trimerization and its lower DNA-binding cooperativity relative to HSF1 explained how the two paralogs differ biochemically despite recognizing the same HSE.\",\n      \"evidence\": \"SELEX, HSE mutagenesis, and chimeric HSF1/HSF2 gel-shift analysis; trimer detection and genomic footprinting in EC cells\",\n      \"pmids\": [\"7935474\", \"8035809\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trimerization and nuclear localization insufficient for in vivo binding in unstressed cells — the gating signal was unidentified\", \"Did not define endogenous activating stimulus\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Identifying proteasome dysfunction as an HSF2 activating signal showed that HSF2 activity is gated by protein stability rather than only by trimerization.\",\n      \"evidence\": \"Proteasome inhibitors and ts85 (E1 mutant) cells with DNA-binding and immunoblot readouts\",\n      \"pmids\": [\"9710593\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Ubiquitin ligase and degron not defined\", \"Link between stabilization and target gene choice unclear\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Mapping HSF2 binding to the PR65/A scaffold of PP2A, competing with the catalytic subunit, suggested HSF2 could influence phosphatase assembly.\",\n      \"evidence\": \"Co-IP and pulldown with PR65 point mutants (K416)\",\n      \"pmids\": [\"10872807\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence for PP2A activity or HSF2 signaling not established\", \"Single lab, no in vivo validation\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Knockout mice assigned HSF2 essential developmental roles, showing it is required for brain development and meiotic progression in gametogenesis.\",\n      \"evidence\": \"Targeted gene disruption with histology and immunohistochemistry (replicated by a second group)\",\n      \"pmids\": [\"12032072\", \"12748967\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets driving the phenotypes not defined in this study\", \"Mechanism of synaptonemal complex defect unresolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrating HSF2–HSF1 interaction and shared localization to nuclear stress granules established physical cross-talk between the paralogs during stress.\",\n      \"evidence\": \"Co-IP, immunofluorescence, deletion mutants, live-cell imaging\",\n      \"pmids\": [\"12865437\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional output of stress-granule localization not defined\", \"Stoichiometry of the HSF1-HSF2 complex unknown at this stage\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Double-knockout epistasis showed HSF1 and HSF2 act additively/synergistically in spermatogenesis, demonstrating overlapping transcriptional programs in germ cells.\",\n      \"evidence\": \"hsf1/hsf2 double-KO mouse genetics, histology, RT-PCR\",\n      \"pmids\": [\"14994269\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve which targets are co-regulated versus paralog-specific\", \"Molecular basis of pachytene arrest unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showing HSF1-HSF2 heterocomplexes bind the clusterin CLE provided direct evidence for heterotrimeric co-occupancy activating a non-Hsp target.\",\n      \"evidence\": \"Gel shift/supershift, ChIP, co-IP, gel filtration, promoter mutation\",\n      \"pmids\": [\"16336210\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Heterotrimer subunit ratio inferred from apparent mass, not directly counted\", \"Generality across promoters not tested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Establishing reciprocal dependency — HSF1 required for maximal HSF2 promoter occupancy — refined how the paralogs jointly control Hsp70 induction.\",\n      \"evidence\": \"ChIP, RT-PCR, HSF2 knockdown/overexpression\",\n      \"pmids\": [\"17213196\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HSF2 acts as activator or modulator context-dependent\", \"No structural basis at this stage\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrating constitutive mitotic HSF2 occupancy of Hsp90, Hsp27 and c-Fos promoters defined HSF2 as a gene-bookmarking factor required for their expression.\",\n      \"evidence\": \"ChIP plus RNAi with protein-level readout\",\n      \"pmids\": [\"17915561\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism allowing binding to condensed chromatin not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identifying MEL-18/UBC9 control of HSF2 SUMOylation and PRC1 interaction during mitosis linked HSF2 modification state to cell-cycle phase and cytokinesis.\",\n      \"evidence\": \"Co-IP, RNAi, overexpression, sumoylation assays, ChIP, co-localization\",\n      \"pmids\": [\"18211895\", \"18570919\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional impact of mitotic SUMOylation on transcription not fully resolved\", \"PRC1-HSF2 link to cytokinesis defect correlative\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"ChIP-chip in testis assigned HSF2 direct regulation of Y-chromosome MSYq multicopy genes required for correct sperm chromatin packaging.\",\n      \"evidence\": \"ChIP-chip, Hsf2 KO mouse, RT-PCR, immunofluorescence, TUNEL; staged ChIP of bookmarking in spermatozoa\",\n      \"pmids\": [\"18682557\", \"18434628\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream chromatin protein regulation mechanism partial\", \"Contribution to post-fertilization genome activation inferred\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showing HSF2 and HSF4 competitively co-repress HIF-1α extended HSF2's repertoire to transcriptional repression with another paralog partner.\",\n      \"evidence\": \"EST screen, ChIP, reporter assay, siRNA, overexpression\",\n      \"pmids\": [\"21258402\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological context of HSF2-HSF4 balance untested in vivo\", \"Single lab\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"A dominant-negative R502H mutation abolishing HSF2 transcriptional function linked HSF2 loss-of-function to idiopathic azoospermia in humans.\",\n      \"evidence\": \"Patient cohort sequencing and functional transcriptional assay of mutant\",\n      \"pmids\": [\"23064888\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causality in patients correlative beyond functional assay\", \"Penetrance and modifier effects unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrating that mitotic decline of HSF2 is required to permit HSF1/Pol II chromatin access reframed HSF2 as a restrictor of stress-inducible transcription during mitosis.\",\n      \"evidence\": \"HSF2 KO/knockdown cells, immunofluorescence, ChIP, flow cytometry, RT-PCR\",\n      \"pmids\": [\"25202032\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism timing HSF2 decline not fully defined\", \"Relationship to bookmarking role nuanced\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identifying an HSE in the HSF2 promoter that mediates negative autoregulation showed HSF2 tunes its own abundance.\",\n      \"evidence\": \"Luciferase reporter, ChIP, RT-PCR after HSF2 transfection\",\n      \"pmids\": [\"26260034\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological conditions where autoregulation dominates unclear\", \"Single lab\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Crystal structures of the HSF2 DBD–DNA complex revealed how a C-terminal helix directs coiled-coil wrapping and exposes paralog-specific surfaces, and confirmed direct HSF1-HSF2 coiled-coil interaction.\",\n      \"evidence\": \"X-ray crystallography and Co-IP of coiled-coil interaction\",\n      \"pmids\": [\"26727490\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length heterotrimer structure not solved\", \"Direct mapping of exposed surfaces to specific modifications not shown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Linking ROS/ERK1/2-driven HSF2 nuclear translocation and deSUMOylation to AT1R/IGF-IIR induction, and miR-18/p53 control of HSF2 levels, placed HSF2 in cardiac stress and hypertrophy signaling.\",\n      \"evidence\": \"Immunofluorescence, DNA-binding, siRNA/overexpression, SUMOylation site mutagenesis (K82), and in vivo cardiac models\",\n      \"pmids\": [\"28295305\", \"29180262\", \"29270451\", \"28796250\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct versus indirect transcriptional contributions partly inferred\", \"Single-lab cardiac models\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showing HSF2-EHMT2 silencing of FBP1 to drive aerobic glycolysis implicated HSF2 in metabolic reprogramming supporting HCC proliferation.\",\n      \"evidence\": \"Co-IP, siRNA, ChIP, proliferation and glycolysis assays\",\n      \"pmids\": [\"31497345\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct HSF2 binding to FBP1 locus versus EHMT2 recruitment not fully separated\", \"Single lab\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identifying HSF1-driven de novo HSF2 transcription during proteasome inhibition explained how HSF2 is induced and contributes to cancer cell migration under proteotoxic stress.\",\n      \"evidence\": \"ChIP, EMSA, reporter assay, RT-PCR, immunofluorescence, migration assay\",\n      \"pmids\": [\"32607595\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Migration mechanism downstream of HSF2 not detailed\", \"Single lab\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrating HSF2 binds ATP-bound HSP90 like HSF1 placed HSF2 within chaperone-mediated regulation of the heat shock response.\",\n      \"evidence\": \"Co-IP with HSP90 mutants in HSF1/HSF2 KO cells\",\n      \"pmids\": [\"34331200\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of HSP90-HSF2 binding for HSF2 activity unclear\", \"Stress response shown HSF1-dependent, HSF2 role secondary\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Acetylation/deacetylation control and shared genome-wide co-occupancy with HSF1 established a stability-and-chromatin axis for HSF2 in neurodevelopment and cancer.\",\n      \"evidence\": \"Co-IP and acetylation assays with patient-derived organoids (CBP/EP300); ChIP-seq, Co-IP and xenografts (HSF1-HSF2 co-regulation)\",\n      \"pmids\": [\"36385105\", \"35294249\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Distinguishing HSF2-unique from HSF1-driven occupancy incomplete\", \"CBP/EP300-HSF2-N-cadherin cascade mechanism partial\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"HDAC1-driven destabilization and TGF-β-mediated downregulation defined HSF2 as a tightly degradation-controlled, stage-specific switch between proliferation and invasion.\",\n      \"evidence\": \"Unbiased Co-IP screen, catalytic mutant and ubiquitination assays, tissue IHC (HDAC1); cell and zebrafish xenograft models with ectopic expression (TGF-β/EMT)\",\n      \"pmids\": [\"40318841\", \"40901953\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase mediating HDAC1-coupled ubiquitination not identified\", \"TGF-β regulation of HSF2 transcription versus stability not fully separated\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Defining an HSF2-HSP110 axis supporting RNA Pol II processivity and CTD Ser7 phosphorylation established HSF2 as a guardian of genome stability whose loss promotes tumorigenesis.\",\n      \"evidence\": \"HSF2/HSP110 KO cells, irradiation assays, Pol II ChIP, CTD phosphorylation Westerns, splicing analysis, in vivo lymphoma model\",\n      \"pmids\": [\"41995727\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular step from HSF2 to CTD Ser7 kinase activity not defined\", \"Whether transcription-factor versus chaperone-cofactor role dominates unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How HSF2's paralog-specific transcriptional outputs, modification states, and partner choices are coordinated to switch between Hsp regulation, developmental programs, metabolic reprogramming and genome maintenance remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking HSF2 PTM state to target gene selection\", \"The E3 ligase(s) and full degron controlling HSF2 turnover are unidentified\", \"Direct versus chaperone-cofactor contributions to Pol II regulation not separated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 8, 9, 12, 17, 27]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 1, 8, 19]},\n      {\"term_id\": \"GO:0003700\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 6, 17, 20, 24]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [10, 17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 8, 9, 27]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [3, 8, 17]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [10, 14, 17]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [5, 7, 12, 26]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [16, 26, 27, 30]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [3, 26, 28]}\n    ],\n    \"complexes\": [\"HSF1-HSF2 heterotrimer\"],\n    \"partners\": [\"HSF1\", \"HSF4\", \"HSP90\", \"HSP110\", \"CREBBP\", \"EP300\", \"HDAC1\", \"UBC9\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":7,"faith_total":7,"faith_pct":100.0}}